There’s no stopping 3D mammography now, but can it sustain this pace?

womens_imaging.png

Seven years after the FDA approved the first tomosynthesis device for breast cancer screening, adoption rates for digital breast tomosynthesis (DBT) remain on an upswing. Earlier this year the agency reported a nearly 30 percent increase of certified mammography facilities offering DBT—aka “3D mammography,” aka “tomo”—over just the past year (from 3,178 facilities in March 2017 to 4,074 in March 2018).

Partial breast irradiation dials down exposure while maintaining quality of life

Low-risk breast cancer patients who opt for accelerated partial breast irradiation—a one-week alternative to traditional whole-breast radiotherapy—see the same quality of life as women who undergo conventional treatment, researchers reported at this year’s European Society for Radiotherapy and Oncology (ESTRO) Congress.

Medical 3D printing is outpacing ways to pay for it

cover.png

While three-dimensional printing has been used in various industries for more than three decades, it took medicine just three or so years to catapult the technology into the popular imagination. Among burgeoning areas of healthcare innovation, probably AI alone has made more headlines in that short a span. And life-size models of individual patients’ organs, which allow surgeons to carefully plan complex procedures and consult with patients and families, are just the start.